I'm LongbridgeAI, I can summarize articles.During Monday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Lakewood-Amedex (LABT), which surged 38.0% to $3.45, and Alamar Biosciences (ALMR), up 7.4% to $32.8. Other gainers were 20/20 Biolabs, SS Innovations Intl, Quantum BioPharma, and ABVC BioPharma. Conversely, losers featured CytoSorbents (CTSO) falling 9.1% to $0.31, SciSparc (SPRC) down 8.35%, BioCardia (BCDA) off 7.9%, Picard Medical (PMI) declining 7.81%, Jupiter Neurosciences (JUNS) dropping 7.07%, and Xtant Medical Holdings (XTNT) falling 6.94%.
Gainers
- Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market session. The company's market cap stands at $5.4 million.
- Alamar Biosciences (NASDAQ:ALMR) stock rose 7.4% to $32.8. The company's market cap stands at $2.1 billion.
- 20/20 Biolabs (NASDAQ:AIDX) shares moved upwards by 7.1% to $0.66. The market value of their outstanding shares is at $7.9 million.
- SS Innovations Intl (NASDAQ:SSII) shares increased by 7.03% to $3.65. The company's market cap stands at $697.3 million.
- Quantum BioPharma (NASDAQ:QNTM) stock increased by 6.9% to $3.39.
- ABVC BioPharma (NASDAQ:ABVC) stock increased by 6.82% to $0.92. The company's market cap stands at $22.1 million.
Losers
- CytoSorbents (NASDAQ:CTSO) stock fell 9.1% to $0.31 during Monday's after-market session. The company's market cap stands at $21.0 million.
- SciSparc (NASDAQ:SPRC) stock declined by 8.35% to $6.08. The company's market cap stands at $3.8 million.
- BioCardia (NASDAQ:BCDA) stock declined by 7.9% to $1.05. The market value of their outstanding shares is at $17.4 million.
- Picard Medical (AMEX:PMI) stock fell 7.81% to $7.8. The company's market cap stands at $18.0 million.
- Jupiter Neurosciences (NASDAQ:JUNS) shares decreased by 7.07% to $3.29. The market value of their outstanding shares is at $5.5 million.
- Xtant Medical Holdings (AMEX:XTNT) stock fell 6.94% to $0.36. The company's market cap stands at $53.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.